![Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers | Antimicrobial Agents and Chemotherapy Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.00200-12/asset/f741e6c8-a8a7-488a-b6fc-f968c794354c/assets/graphic/zac9991011730001.jpeg)
Safety, Tolerability, and Pharmacokinetics of Intravenous Oseltamivir: Single- and Multiple-Dose Phase I Studies with Healthy Volunteers | Antimicrobial Agents and Chemotherapy
![Multiple-dose study. (A) Mean avatrombopag concentration time profiles... | Download Scientific Diagram Multiple-dose study. (A) Mean avatrombopag concentration time profiles... | Download Scientific Diagram](https://www.researchgate.net/publication/327578320/figure/fig1/AS:669659615465490@1536670702612/Multiple-dose-study-A-Mean-avatrombopag-concentration-time-profiles-on-days-1-and-14.png)
Multiple-dose study. (A) Mean avatrombopag concentration time profiles... | Download Scientific Diagram
![PDF] Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age. | Semantic Scholar PDF] Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/168f1250036d7761525361015074a1a817a3139b/7-Figure1-1.png)
PDF] Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age. | Semantic Scholar
![Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects | Antimicrobial Agents and Chemotherapy Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.02181-16/asset/9a362f05-4e0d-41a8-8148-b433dfcd28ad/assets/graphic/zac0041760640002.jpeg)
Single- and Multiple-Dose Study To Determine the Safety, Tolerability, Pharmacokinetics, and Food Effect of Oral MRX-I versus Linezolid in Healthy Adult Subjects | Antimicrobial Agents and Chemotherapy
![Study design. The first dose in the multiple-dose dose-escalation phase... | Download Scientific Diagram Study design. The first dose in the multiple-dose dose-escalation phase... | Download Scientific Diagram](https://www.researchgate.net/publication/281610551/figure/fig3/AS:340543772086278@1458203371032/Study-design-The-first-dose-in-the-multiple-dose-dose-escalation-phase-was-administered.png)
Study design. The first dose in the multiple-dose dose-escalation phase... | Download Scientific Diagram
![Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0149291815011777-gr1.jpg)
Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age - ScienceDirect
![Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study | springermedizin.de Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study | springermedizin.de](https://media.springernature.com/lw150/springer-static/cover/journal/13318/42/4.jpg?as=jpg)
Multiple Dose Pharmacokinetics and Safety of Sulcardine Sulfate in Healthy Chinese Male Subjects: An Open-Label Phase I Clinical Study | springermedizin.de
![Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary](https://pharmacylibrary.com/cms/10.21019/9781582121260.ch22/asset/images/medium/rits7_c022f005.gif)
Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary
![Metabolites | Free Full-Text | Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study Metabolites | Free Full-Text | Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study](https://pub.mdpi-res.com/metabolites/metabolites-12-01281/article_deploy/html/images/metabolites-12-01281-g001.png?1671200810)
Metabolites | Free Full-Text | Optimising Fluvoxamine Maternal/Fetal Exposure during Gestation: A Pharmacokinetic Virtual Clinical Trials Study
![A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers - Hazan - 2020 - Clinical Pharmacology in Drug Development - Wiley Online Library A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers - Hazan - 2020 - Clinical Pharmacology in Drug Development - Wiley Online Library](https://accp1.onlinelibrary.wiley.com/cms/asset/43761d42-355b-4e86-97ab-0cf6dd994e32/cpdd720-fig-0002-m.jpg)
A First‐in‐Human Phase 1 Randomized Single and Multiple Ascending Dose Study of RPh201 in Healthy Volunteers - Hazan - 2020 - Clinical Pharmacology in Drug Development - Wiley Online Library
![Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products - ScienceDirect Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0378517311010635-fx1.jpg)
Investigation on the need of multiple dose bioequivalence studies for prolonged-release generic products - ScienceDirect
![Frontiers | Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers Frontiers | Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers](https://www.frontiersin.org/files/Articles/324416/fphar-08-00965-HTML/image_m/fphar-08-00965-g001.jpg)
Frontiers | Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers
![Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary](https://pharmacylibrary.com/cms/10.21019/9781582121260.ch22/asset/images/medium/rits7_c022f009.gif)
Chapter 22. Pharmacokinetics of Multiple Dosing | Handbook of Basic Pharmacokinetics… Including Clinical Applications, 7th Edition | PharmacyLibrary
![Safety, Tolerability, Pharmacokinetics and Antiviral Activity following Single- and Multiple-Dose Administration of BMS-650032, a Novel HCV NS3 Inhibitor, in Subjects with Chronic Genotype 1 HCV Infection Safety, Tolerability, Pharmacokinetics and Antiviral Activity following Single- and Multiple-Dose Administration of BMS-650032, a Novel HCV NS3 Inhibitor, in Subjects with Chronic Genotype 1 HCV Infection](https://www.natap.org/2010/images/033010/033010-1/image008.gif)
Safety, Tolerability, Pharmacokinetics and Antiviral Activity following Single- and Multiple-Dose Administration of BMS-650032, a Novel HCV NS3 Inhibitor, in Subjects with Chronic Genotype 1 HCV Infection
![A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12890-018-0763-9/MediaObjects/12890_2018_763_Fig4_HTML.png)
A phase I, randomized, observer-blinded, single and multiple ascending-dose study to investigate the safety, pharmacokinetics, and immunogenicity of BITS7201A, a bispecific antibody targeting IL-13 and IL-17, in healthy volunteers | BMC Pulmonary
![Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients - Cantillon - 2018 - Clinical and Translational Science - Wiley Online Library Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients - Cantillon - 2018 - Clinical and Translational Science - Wiley Online Library](https://ascpt.onlinelibrary.wiley.com/cms/asset/84c1c0ca-c963-4f5c-8fd3-ffacd4d57463/cts12518-fig-0001-m.jpg)
Pharmacokinetics of RP5063 Following Single Doses to Normal Healthy Volunteers and Multiple Doses Over 10 Days to Stable Schizophrenic Patients - Cantillon - 2018 - Clinical and Translational Science - Wiley Online Library
![Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota | Antimicrobial Agents and Chemotherapy Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota | Antimicrobial Agents and Chemotherapy](https://journals.asm.org/cms/10.1128/AAC.01395-19/asset/95f59352-97b0-47d8-9045-7db922e49b35/assets/graphic/aac.01395-19-f0001.jpeg)
Multiple-Ascending-Dose Phase 1 Clinical Study of the Safety, Tolerability, and Pharmacokinetics of CRS3123, a Narrow-Spectrum Agent with Minimal Disruption of Normal Gut Microbiota | Antimicrobial Agents and Chemotherapy
![CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research | DAIC CinCor Pharma Announces Publication of Phase 1 Multiple Ascending Dose Study Data in Hypertension Research | DAIC](https://www.dicardiology.com/sites/default/files/styles/content_feed_large_new/public/Screen%20Shot%202022-10-21%20at%2010.29.05%20AM.png?itok=OoAyZ53E)